Biofrontera Inc. Common Stock
$1.32
$0.08 (+6.45%)
$1.27Day Range$1.33
Key Statistics
Market Cap
$19.61M
Shares Outstanding
14.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 29, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$1.29
Day High
$1.33
Day Low
$1.27
Volume
378.3K
VWAP
$1.31
Prev Close
$1.24
Transactions
--
Acc. Volume
--
About Biofrontera Inc. Common Stock
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
PHARMACEUTICAL PREPARATIONSSIC 283494 employees120 PRESIDENTIAL WAY,, WOBURN, MA, 01801781-245-1325IPO Oct 29, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001858685
- Composite FIGI
- BBG00HTD0PX0
- Share Class FIGI
- BBG00HTD0PY9
- Ticker Root
- BFRI
- SIC Code
- 2834
About Biofrontera Inc. Common Stock (BFRI) Stock
Biofrontera Inc. Common Stock (BFRI) closed the 2026-09-18 session at $1.32, up 6.45% versus the previous close (+0.08). The stock opened at $1.29 and traded between $1.27 and $1.33 during that session. Session trading volume was 378K shares. The volume-weighted average price (VWAP) is $1.31.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
Biofrontera Inc. Common Stock has a market capitalization of $19.6 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. BFRI is listed on the XNAS exchange. The company employs approximately 94 people. Biofrontera Inc. Common Stock is headquartered in WOBURN, MA. The recorded listing date is 2021-10-29.
On this page you can find market BFRI stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.